Back

Early inhibition of renin-aniotensin-aldosterone system is associated with improved left ventricular function in STEMI survivors without previous hypertension: a two dimensional speckle-tracking study

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Chronic heart failure (CHF) Ventricular function / haemodynamics ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Uyanga Ganbat

China Medical University Hospital, Taichung (Taiwan)

28 More presentations in this session

Presentation thumbnail
Doctor A. Tomasik (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Doctor J. Lagan (Chester, GB)
Abstract Slides
Presentation thumbnail
Miss S. Brun (Toulouse, FR)
Abstract Slides
Presentation thumbnail
Doctor J. Wang (Jinan, CN)
Abstract Slides
Presentation thumbnail
Professor S. Baratta (Pilar, AR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Chronic heart failure (CHF)

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Role of aldosterone in long-term left ventricular remodelling after acute myocardial infarction: the REMI study
22 May 2023
thumbnail
Congress Presentation
Early versus delayed introduction of renin angiotensin aldosterone system inhibitors in cardiogenic shock
27 August 2023
thumbnail
Congress Presentation
Right ventricular longitudinal systolic strain as a predictor of new onset heart failure with preserved ejection fraction in hypertensive patients.
27 August 2021
thumbnail
Congress Presentation
Rapid pharmacological optimisation with an ARNI (sacubitril/valsartan) in de novo severe LV systolic dysfunction: effects on left ventricular systolic function and time to optimisation of therapy
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources